Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Boston-based Anodyne plans to use proceeds to support the advancement of ANN-101, its once-weekly GLP-1 patch for obesity
As GLP-1 drugs become more mainstream, I think the impacts are going to become increasingly clear
What to Watch For Standard Commercial Plans Wegovy's preferred status from July 2025 is expected to continue
Med 335 , 11691175 (1996)
In trials, users experienced decreases in fasting blood sugar and significant reductions in HbA1c, a measurement of long-term blood sugar management
US$ 20.14
US$ 24.04
US$ 22.85
US$ 22.27
US$ 22.61
US$ 28.04
